ESP-001
N/A
Report date: 2024/06/05 10:33:25
NME
Base Information
Drug NameESP-001
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[4]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesEsperas Pharma Inc
Inactive CompaniesN/A
Active Indications +[10]
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A